Evidence map›Paper›PMID 26208597›Full record

ArticleJournal of molecular neuroscience : MN2015

Geldanamycin Reduces Aβ-Associated Anxiety and Depression, Concurrent with Autophagy Provocation.

Nayereh Zare, Solmaz Khalifeh, Fariba Khodagholi, Shima Zareh Shahamati, Fereshteh Motamedi, Nader Maghsoudi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. TRAP1 in Oxidative Stress and Neurodegeneration.Antioxidants (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nayereh ZareNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Solmaz KhalifehMedical Genomics Research Center and School of Advanced Sciences in Medicine, Islamic Azad University, Tehran Medical Sciences Branch, Tehran, Iran.
Fariba KhodagholiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shima Zareh ShahamatiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fereshteh MotamediNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nader MaghsoudiNeuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. nmaghsoudi@sbmu.ac.ir.
Shahid Beheshti University of Medical Sciences · IRIslamic Azad University Medical Branch of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodegenerative disorders are generally characterized by abnormal aggregation and deposition of specific proteins. Amyloid beta (Aβ)-associated neurodegenerative disorder is characterized by an oxidative damage that, in turn, leads to some behavioral changes before the establishment of dementia such as depression and anxiety. In the current study, we investigated the effect of heat shock protein 90 inhibitor geldanamycin (GA) administration 24 h before Aβ injection. In our experiment, 7 days after Aβ injection, elevated plus maze and forced swimming test were conducted to assess anxiety and depression-like behaviors. Levels of autophagy markers and malondialdehyde (MDA) and also activity of catalase in the hippocampus of rats were evaluated. Our behavioral analyses demonstrated that GA pretreatment can significantly decrease anxiety- and depression-like behaviors in Aβ-injected rats. Also, levels of autophagy markers including Atg12, Atg7, and LC3-II increased, while MDA level decreased and the activity of catalase increased in rats pretreated with GA compared to Aβ-injected rats. Thus, we assumed that GA, at least in part, ameliorated Aβ-mediated anxiety and depression by inducing autophagy and improving antioxidant defense system.

Indexed as

Amyloid beta-PeptidesAnimalsAnxietyAutophagyBenzoquinonesBiomarkersCatalaseDepressionDrug Evaluation, PreclinicalExploratory BehaviorFatigueHippocampusHSP90 Heat-Shock ProteinsInjections, IntraventricularLactams, MacrocyclicMaleAmyloid beta-PeptidesBenzoquinonesBiomarkersCatalasegeldanamycinHSP90 Heat-Shock ProteinsLactams, MacrocyclicMalondialdehydeNerve Tissue ProteinsNeuroprotective AgentsAmyloid-βAnxietyAutophagyDepressionGeldanamycinHSP90

Identifiers

PMID26208597
OpenAlexW958546763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.